Abstract
Obesity is one of the major public health problems worldwide and it is generally associated with many diseases. Although synthetic drugs are available for the treatment of obesity, herbal remedies may provide safe, natural, and cost-effective alternative to synthetic drugs. One example of such drugs is Melastoma malabathricum var Alba Linn (MM). Although several studies have been reported for the pharmacological activities of MM, there is no report on the anti-obesity effect of MM. The aim of the present study is to evaluate the anti-obesity potential of methanolic extract of MM. The anti-obesity effect of MM on rats fed with a high-fat diet was investigated through determination of the changes in body weight, fat weight, organ weights, and blood biochemicals. The animals in this study were divided into three groups: a normal group with a standard diet (N), a control group fed with high-fat diet (C), and a MM treatment group fed with high-fat (HFD + MM) diet for 8 weeks. There was no significant difference in the amount of food intake between control and HFD + MM treatments. These results also suggest that MM does not induce a dislike for the diet due to its smell or taste. The study shows that MM significantly prevented increases in body weight, cholesterol, LDL, HDL, and total lipids that resulted from the high-fat diet. MM also decreased the epididymal fat (E-fat) and retroperitoneal fat (R-fat) weights and phospholipid concentrations induced by the high-fat diet. On the basis of these findings, it was concluded that MM had anti-obesity effects by suppressing body weight gain and abdominal fat formation.
Similar content being viewed by others
References
Mangal A, Sharma MC. Evaluation of certain medicinal compounds for antiobesity properties. Indian J Trad Knowl. 2009;8(4):602–5.
Ekanem AP, Wang M, Simon JE, Moreno DA. Antiobesity properties of two African plants (Afromomum meleguetta and Spilanthes acmella) by pancreatic lipase inhibition. Phytother Res. 2007;21:1253–5.
Frank BH, Li TY, Graham AC, Walter CW, JoAnn EM. Television watching and other sedentary, behaviors in relation to risk of obesity and type 2 diabetes mellitus in women. JAMA. 2003;289:1785–91.
Bays H, Blonde L, Rosenson R. Adiposopathy: how do diet, exercise and weight loss drug therapies improve metabolic disease in overweight patients? Expert Rev of Cardiovasc Ther. 2006;4:871–95.
Mazzucotelli A, Lanqin D. Fatty acid mobilization and their use in adipose tissue. J de la Socié té de Biol. 2006;200:83–91.
Ranjbar SH, Nayebi N, Larijani B, Abdollahi M. A systematic review of the efficacy and safety of herbal medicines used in the treatment of obesity. World J Gastroenterol. 2009;15(25):3073–85.
Hardeman W, Griffin S, Johnston M, Kinmonth AL, Wareham NJ. Interventions to prevent weight gain: a systematic review of psychological models and behaviour change methods. Int J Obes Relat Metab Disord. 2000;24:131–43.
Abdollahi M, Afshar-Imani B. A review on obesity and weight loss measures. Middle East Pharm. 2003;11:6–10.
Begum D, Nath SC. Ethnobotanical review of medicinal plants used for skin diseases and related problems in Northeastern India. J Herbs Spices Med Plants. 2000;7(3):55–93.
Ong HC, Norzalina J. Malay herbal medicine in Gemencheh, Negri Sembilan. Malaysia Fitoterapia. 1999;70(1):10–4.
Mohd JS, Yob NJ, Rofiee MS, Meor Mohd MMR, Affandi Z, Suhaili F, et al. Melastoma malabathricum (L) Smith ethnomedicinal uses, chemical constituents, and pharmacological properties: a review. Evid Based Complement Alternat Med. 2011;2012:1–48.
Folch J, Lees M, Sloane-Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 1957;226:479–509.
Kusnoki M, Hara T, Tsutsumi K, Nakamura T, Miyata T, Sakakibara F, et al. The lipoprotein lipase activator, NO-1886, suppresses fat accumulation and insulin resistance in rats fed a high-fat diet. Diabetologia. 2000;43(7):875–80.
Bobek P, Hromadova M, Ozdin L. Experientia. Oyster mushroom (Pleurotus ostreatus) reduces the activity of 3-hydroxy-3-methylglutaryl CoA reductase in rat liver microsomes. Experientia. 1995;51(6):589–91.
Kesaniemi YA, Grundy SM. Effects of dietary polyenylphosphatidylcholine on metabolism of cholesterol and triglycerides in hypertriglyceridemic patients. Am J Clin Nutr. 1986;43:98–107.
Hauptman JB, Jeunet FS, Hartmann D. Initial studies in humans with the novel gastrointestinal lipase inhibitor Ro 18–0647 (tetrahydrolipstatin). Am J Clin Nutr. 1992;55:309S–13.
Lowry JB. The distribution and potential taxonomic value of alkylated ellagic acids. Phytochemistry. 1968;7(10):1803–13.
Lowry JB. Anthocyanins of the Melastomataceae, Myrtaceae and some allied families. Phytochemistry. 1976;15(4):513–6.
Manzoor-I-Khuda M, Chowdhury SA, Reza T, Chowdhury AK. Chemical investigation on Melastoma malabathricum. Part 1: isolation of melastomic acid and beta-sitosterol from the roots. J Bangladesh Acad Sci. 1981;5:55–9.
Dinda B, Saha MK. Aliphatic compounds from Melastoma malabathricum. J Indian Chem Soc. 1986;63:764–6.
Dinda B, Saha MK. Fatty acid sterols from Melastoma malabathricum. J Indian Chem Soc. 1986;63:144–5.
Dass KK, Kotoky JJ. A new aliphatic constituent of Melastoma malabathricum Linn. J Indian Chem Soc. 1988;65:385–6.
Dinda B, Saha MK. A flavonol-diglycoside from Melastoma malabathricum. J Indian Chem Soc. 1988;65:209–11.
Yoshida T, Nakata F, Hosotani K, Nitta A, Okuda T. Dimeric hydrolysable tannins from Melastoma malabathricum. Phytochemistry. 1992;31:2829–33.
Yoshida T, Nakata F, Hosotani K, Nitta A, Okuda T. Tannins and related polyphenols of melastomataceous plants. V. Three new complex tannins from Melastoma malabathricum L. Chem Pharm Bull. 1992;40(7):1727–32.
Nuresti S, Baek SH, Asari A. Chemical components of Melastoma malabathricum. ACGC Chem Res Commun. 2003;16:28–33.
Wong KC, Boey PL, Ali DMH. Phytochemical and biological study of Melastoma malabathricum L., a local plant used in traditional medicine. MIDAS Bull. 2004;32:8cbrs.
Nazlina I, Norha S, Noor Zarina AW, Ahmad IB. Cytotoxicity and antiviral activity of Melastoma malabathricum extracts. Malaysian J App Bio. 2008;37:53–5.
Susanti D, Sirat HM, Ahmad F, Mat AR. Bioactive constituents from the leaves of Melastoma malabathricum L. J Ilmiah Farmasi. 2008;5:1–8.
Bose M, Lambert JD, Ju J, Reuhl KR, Shapses SA, Yang CS. The major green tea polyphenol, (−)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice. J Nutr. 2008;138:1677–83.
Wolfram S, Raederstorff D, Wang Y, Teixeira SR, Elste V, Weber P. TEAVIGO (epigallocatechin gallate) supplementation prevents obesity in rodents by reducing adipose tissue mass. Ann Nutr Metab. 2005;49:54–63.
Klaus S, Pultz S, Thone-Reineke C, Wolfram S. Epigallocatechin gallate attenuates diet-induced obesity in mice by decreasing energy absorption and increasing fat oxidation. Int J Obes. 2005;29:615–23.
Yu SF, Shun CT, Chen TM, Chen YH. 3-O-beta-D-glucosyl-(1→6)-beta-D-glucosyl-kaempferol isolated from Sauropus androgenus reduces body weight gain in Wistar rats. Biol Pharm Bull. 2006;29:2510–3.
Park T, Kim Y. Phytochemicals as potential agents for prevention and treatment of obesity and metabolic diseases. Anti Obes Drug Discov Dev. 2011;1:1–47.
Hsu CL, Yen GC. Effects of flavonoids and phenolic acids on the inhibition of adipogenesis in 3T3-L1adipocytes. J Agric Food Chem. 2007;55:8404–10.
Hsu CL, Wu CH, Huang SL, Yen GC. Phenolic compounds rutin and o-coumaric acid ameliorate obesity induced by high-fat diet in rats. J Agric Food Chem. 2009;57:425–31.
Acknowledgments
This research work was financially supported by the Universiti Sains Malaysia, under the Grant No. 304/PFarmasi/650603/K123.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Karupiah, S., Ismail, Z. Anti-Obesity Effects of Melastoma malabathricum var Alba Linn in Rats Fed with a High-Fat Diet. AAPS PharmSciTech 16, 548–553 (2015). https://doi.org/10.1208/s12249-014-0245-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12249-014-0245-1